Idiopathic Short Stature clinical trials at UCSF

2 research studies open to eligible people

Showing trials for

  • Vosoritide in Children With Idiopathic Short Stature

    open to eligible people ages 3-11

    The purpose of this study is to evaluate i) the effect of multiple doses of vosoritide and ii) the effect of the therapeutic dose of vosoritide compared to human growth hormone (hGH)(hGH; only in the United States), in children with idiopathic short stature (ISS).

    Oakland, California and other locations

  • Growth in Children With Idiopathic Short Stature

    open to eligible people ages 2-16

    Study 111-903 will generate baseline growth data in children with ISS by collecting growth measurements and other variables of interest.

    San Francisco, California and other locations

Last updated: